During the past decade, Elkins Pancreas Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Elkins Pancreas Center" are "Pancreatic Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Neoplasm Metastasis" (1 trials). Many other conditions were trialed in "Elkins Pancreas Center" in a lesser frequency.

Most popular intervention types in "Elkins Pancreas Center" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PANVAC™-VF" (1 trials), "gemcitabine" (1 trials) and "talabostat mesylate tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elkins Pancreas Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Elkins Pancreas Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Elkins Pancreas Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Elkins Pancreas Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".